Literature DB >> 856250

Sulphydryl group modification of aspartate aminotransferase with 3-bromo-1,1,1-trifluoropropanone during catalysis.

W J Critz, M Martinez-Carrion.   

Abstract

After protection of cysteine-45 and -82 with iodoacetamide or N-ethylmaleimide, and in the presence of saturating concentrations of substrates, the supernatant isozyme of pig heart aspartate transaminase has been covalently modified at cysteine-390 with 3-bromo-1,1,1-trifluoropropanone. The modified enzyme retains 60-70% of the initial specific activity and is similar to native enzyme in pH and temperature stability. After tagging cysteine-390 with the fluorinated compound, the enzyme retains substrate and inhibitor binding abilities; as shown by direct spectrophotometric titration of the active-site chromophores. The 19F NMR spectrum of the modified enzyme has been obtained by a Fourier transform NMR method. Although the transaminase is a dimeric enzyme, 19F bound at each subunit's cysteine-390 gives rise to only a single 19F resonance upfield from that of trifluoroacetic acid. The fact that the chemical shifts of the 19F probe differ in native and guanidine hydrochloride (Gdn-HCl) denatured enzyme is interpreted as the effect of the native protein groups on the probe. The discordance between the changes induced by varying concentrations of Gdn-HCl on the 19F resonance parameters, on the one hand, and the changes in enzyme activity and prosthetic group absorbance, on the other, suggests that, in aspartate transaminase, cysteine-390 lies in an environment dissimilar from that of the active-site components.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 856250     DOI: 10.1021/bi00627a004

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  1 in total

1.  The amino acid sequence of cytosolic aspartate aminotransferase from human liver.

Authors:  J M Doyle; M E Schininà; F Bossa; S Doonan
Journal:  Biochem J       Date:  1990-09-15       Impact factor: 3.857

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.